ERYTECH Pharma S.A. Total Liabilities 2011-2026 | ERYP

Annual Total Liabilities ERYTECH Pharma S.A.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	53.9 M	33 M	22.2 M	13.8 M	9.33 M	5.87 M	4.78 M	4.36 M	14.2 M	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
53.9 M	4.36 M	17.9 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Autolus Therapeutics plc AUTL	411 M	$ 1.34	-3.6 %	$ 357 M	Britain
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
DBV Technologies S.A. DBVT	64.9 M	$ 20.13	-1.13 %	$ 2.81 B	France
Alterity Therapeutics Limited ATHE	5.89 M	$ 3.65	1.3 %	$ 8.78 B	Australia
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Dyadic International DYAI	8.71 M	$ 0.87	-	$ 31.5 M	USA
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	93.3 M	$ 2.57	-3.57 %	$ 16.1 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Equillium EQ	3.29 M	$ 2.04	1.24 %	$ 117 M	USA
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
Fate Therapeutics FATE	57.5 M	$ 1.13	-5.04 %	$ 134 M	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Forte Biosciences FBRX	21.8 M	$ 26.57	0.49 %	$ 344 M	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
Fennec Pharmaceuticals FENC	35.1 M	$ 6.14	-4.36 %	$ 175 M	USA
Foghorn Therapeutics FHTX	307 M	$ 4.74	-2.87 %	$ 299 M	USA
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
Amicus Therapeutics FOLD	676 M	$ 14.46	0.03 %	$ 4.46 B	USA
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
Fulcrum Therapeutics FULC	17.3 M	$ 7.55	-3.58 %	$ 478 K	USA
Galectin Therapeutics GALT	146 M	$ 2.25	-12.3 %	$ 144 M	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
BioNTech SE BNTX	2.76 B	$ 87.65	-3.98 %	$ 27.2 B	Germany
Gilead Sciences GILD	39 B	$ 138.19	-1.38 %	$ 172 B	USA
Coherus BioSciences CHRS	197 M	$ 1.61	-3.59 %	$ 189 M	USA
Akari Therapeutics, Plc AKTX	19.6 M	$ 3.5	-1.13 %	$ 236 B	Britain
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Galmed Pharmaceuticals Ltd. GLMD	8.23 M	$ 0.54	4.26 %	$ 503 K	Israel
Genmab A/S GMAB	2.02 B	$ 27.01	-2.67 %	$ 17.2 B	Danmark
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	4.18 B	$ 314.44	-4.81 %	$ 41.2 B	USA
Gossamer Bio GOSS	295 M	$ 0.32	-7.11 %	$ 73.1 M	USA
Grifols, S.A. GRFS	12.8 B	$ 7.91	-3.95 %	$ 6.83 B	Spain
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
GT Biopharma GTBP	1.32 M	$ 0.42	-6.49 %	$ 2.32 M	USA
Aileron Therapeutics ALRN	7.24 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Halozyme Therapeutics HALO	2.48 B	$ 63.51	0.68 %	$ 7.61 B	USA
Burford Capital Limited BUR	1.45 B	$ 4.42	-1.34 %	$ 727 M	Britain